Access the full text.
Sign up today, get DeepDyve free for 14 days.
KB Hoffman, M Dimbil, CB Erdman, NP Tatonetti, BM Overstreet (2014)
The Weber effect and the United States Food and Drug Administration?s Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010, 37
Castinetti (2019)
G1Endocr Relat Cancer., 26
Charmandari (2014)
2152Lancet., 383
Laugesen (2019)
e0212259PLoS One., 14
LL Benitez, PL Carver (2019)
Adverse effects associated with long-term administration of azole antifungal agents, 79
Li (2020)
1291Endocr Pract., 26
Grouthier (2020)
696Oncologist., 25
CM Berr, G Di Dalmazi, A Osswald (2015)
Time to recovery of adrenal function after curative surgery for Cushing?s syndrome depends on etiology, 100
Q Guo, W Lu, X Sun, Z Zhao, L Liu (2021)
Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients, 157
Broersen (2015)
2171J Clin Endocrinol Metab., 100
BJ Schneider, J Naidoo, BD Santomasso (2021)
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update, 39
Bénard-Laribière (2017)
e015905BMJ Open., 7
Faillie (2019)
225Therapie., 74
Laugesen (2019)
267Eur J Endocrinol., 181
Laugesen (2021)
R111Eur J Endocrinol., 184
Woods (2015)
633Eur J Endocrinol., 173
CP Woods, N Argese, M Chapman (2015)
Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol, 173
S Hescot, M Haissaguerre, P Pautier, E Kuhn, M Schlumberger, A Berdelou (2018)
Immunotherapy-induced Addison?s disease: a rare, persistent and potentially lethal side-effect, 97
Hoffman (2014)
971Drug Saf., 37
A Prete, I Bancos (2021)
Glucocorticoid induced adrenal insufficiency, 374
KB Hoffman, AR Demakas, M Dimbil, NP Tatonetti, CB Erdman (2014)
Stimulated reporting: the impact of US Food and Drug Administration-issued alerts on the Adverse Event Reporting System (FAERS), 37
AC Paepegaey, C Lheure, C Ratour (2017)
Polyendocrinopathy resulting from pembrolizumab in a patient with a malignant melanoma, 1
Hoener (2019)
e230760BMJ Case Rep., 12
Z Hochberg, K Pacak, GP Chrousos (2003)
Endocrine withdrawal syndromes, 24
Di Dalmazi (2014)
2637J Clin Endocrinol Metab., 99
E Charmandari, NC Nicolaides, GP Chrousos (2014)
Adrenal insufficiency, 383
Prete (2021)
n1380BMJ., 374
Fukazawa (2018)
1402Pharmacoepidemiol Drug Saf., 27
Raschi (2020)
449Target Oncol., 15
K Laugesen, I Petersen, HT Sørensen, JOL Jørgensen (2019)
Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: a Danish population-based self-controlled case series analysis, 14
Barroso-Sousa (2018)
173JAMA Oncol., 4
H Trainer, P Hulse, CE Higham, P Trainer, P Lorigan (2016)
Hyponatraemia secondary to nivolumab-induced primary adrenal failure, 2016
Min (2013)
e15Lancet Diabetes Endocrinol., 1
Saberi (2013)
519HIV Med., 14
LCCJ Smans, ES Van der Valk, ARMM Hermus, PMJ Zelissen (2016)
Incidence of adrenal crisis in patients with adrenal insufficiency, 84
JJ Wright, AC Powers, DB Johnson (2021)
Endocrine toxicities of immune checkpoint inhibitors, 17
K Laugesen, LHA Broersen, SB Hansen, OM Dekkers, HT Sørensen, JOL Jørgensen (2021)
Management of endocrine disease: glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?, 184
TE Warkentin, EL Safyan, LA Linkins (2015)
Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages, 372
Bornstein (2019)
561Nat Rev Endocrinol., 15
Bacanovic (2015)
e518Clin Nucl Med., 40
LHA Broersen, AM Pereira, JOL Jørgensen, OM Dekkers (2015)
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis, 100
Raschi (2021)
581Br J Dermatol., 184
Raschi
The changing face of drug-induced adrenal insufficiency in the Food and Drug Administration Adverse Event Reporting System.?Supplementary data for
E Raschi, M Gatti, F Gelsomino, A Ardizzoni, E Poluzzi, F De Ponti (2020)
Lessons to be learnt from real-world studies on immune-related adverse events with checkpoint inhibitors: a clinical perspective from pharmacovigilance, 15
Cao (2014)
530Nat Rev Endocrinol., 10
Warkentin (2015)
492N Engl J Med., 372
JBAG Haanen, F Carbonnel, C Robert (2017)
Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, 28
L Fardet, I Petersen, I Nazareth (2011)
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years, 50
A Haslam, V Prasad (2019)
Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs, 2
V Grouthier, B Lebrun‐Vignes, M Moey (2020)
Immune checkpoint inhibitor?associated primary adrenal insufficiency: WHO VigiBase report analysis, 25
S Bacanovic, IA Burger, P Stolzmann, J Hafner, MW Huellner (2015)
Ipilimumab-induced adrenalitis: a possible pitfall in 18F-FDG-PET/CT, 40
Smrecnik (2018)
1675Osteoporos Int., 29
P Saberi, T Phengrasamy, D Nguyen (2013)
Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management, 14
Fardet (2011)
1982Rheumatology (Oxford)., 50
Berr (2015)
1300J Clin Endocrinol Metab., 100
Haanen (2017)
iv119Ann Oncol., 28
Hochberg (2003)
523Endocr Rev., 24
Smans (2016)
17Clin Endocrinol (Oxf)., 84
C Fukazawa, Y Hinomura, M Kaneko, M Narukawa (2018)
Significance of data mining in routine signal detection: analysis based on the safety signals identified by the FDA, 27
Y Cao (2014)
VEGF-targeted cancer therapeutics?paradoxical effects in endocrine organs, 10
C Colombo, S De Leo, M Di Stefano, G Vannucchi, L Persani, L Fugazzola (2019)
Primary adrenal insufficiency during lenvatinib or vandetanib and improvement of fatigue after cortisone acetate therapy, 104
Trainer (2016)
1-4Endocrinol Diabetes Metab Case Rep., 2016
M Smrecnik, Z Kavcic Trsinar, T Kocjan (2018)
Adrenal crisis after first infusion of zoledronic acid: a case report, 29
SA Reines, B Goldmann, M Harnett, L Lu (2020)
Misuse of tramadol in the United States: an analysis of the National Survey of Drug Use and Health 2002-2017, 14
Joseph (2016)
133Semin Arthritis Rheum., 46
(1952)
Iatrogenic adrenal insufficiency, 150
K Hoener, T Sharma (2019)
Type II polyglandular autoimmune syndrome: a case of Addison?s disease precipitated by use of levothyroxine, 12
Haslam (2019)
e192535JAMA Netw Open., 2
J Am Med Assoc., 150
Wright (2021)
389Nat Rev Endocrinol., 17
Raschi (2019)
205Target Oncol., 14
L Min, N Ibrahim (2013)
Ipilimumab-induced autoimmune adrenalitis, 1
RM Joseph, AL Hunter, DW Ray, WG Dixon (2016)
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review, 46
SR Bornstein, TD Bornstein, CL Andoniadou (2019)
Novel medications inducing adrenal insufficiency, 15
Tan (2019)
1Clin Diabetes Endocrinol., 5
Mifsud (2021)
351Expert Rev Endocrinol Metab., 16
Paepegaey (2017)
646J Endocr Soc., 1
DY Wang, JE Salem, JV Cohen (2018)
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis, 4
Benitez (2019)
833Drugs., 79
JL Faillie (2019)
Case-non-case studies: principle, methods, bias and interpretation, 74
A Bénard-Laribière, A Pariente, E Pambrun, B Bégaud, L Fardet, P Noize (2017)
Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France, 7
Guo (2021)
358Eur J Cancer., 157
Colombo (2019)
779J Clin Endocrinol Metab., 104
Raschi (2018)
533Nutr Metab Cardiovasc Dis., 28
I Bancos, S Hahner, J Tomlinson, W Arlt (2015)
Diagnosis and management of adrenal insufficiency, 3
Hoffman (2014)
283Drug Saf., 37
Bancos (2015)
216Lancet Diabetes Endocrinol., 3
Hescot (2018)
57Eur J Cancer., 97
R Barroso-Sousa, WT Barry, AC Garrido-Castro (2018)
Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis, 4
T Li, D Donegan, WM Hooten, I Bancos (2020)
Clinical presentation and outcomes of opioid-induced adrenal insufficiency, 26
K Laugesen, JOL Jørgensen, I Petersen, HT Sørensen (2019)
Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark, 181
E Raschi, A Mazzarella, IC Antonazzo (2019)
Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system, 14
E Raschi, M La Placa, E Poluzzi, F De Ponti (2021)
The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice, 184
MH Tan, R Iyengar, K Mizokami-Stout (2019)
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports, 5
S Mifsud, Z Gauci, M Gruppetta, C Mallia Azzopardi, S Fava (2021)
Adrenal insufficiency in HIV/AIDS: a review, 16
E Raschi, E Poluzzi, F Salvo (2018)
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems, 28
Reines (2020)
1178221820930006Subst Abuse., 14
Schneider (2021)
4073J Clin Oncol., 39
F Castinetti, F Albarel, F Archambeaud (2019)
French Endocrine Society guidance on endocrine side effects of immunotherapy, 26
G Di Dalmazi, CM Berr, M Fassnacht, F Beuschlein, M Reincke (2014)
Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing?s syndrome: a systematic review of the literature, 99
Wang (2018)
1721JAMA Oncol., 4
ContextAdrenal insufficiency (AI) is a life-threatening condition complicating heterogeneous disorders across various disciplines, with challenging diagnosis and a notable drug-induced component.ObjectiveThis work aimed to describe the spectrum of drug-induced AI through adverse drug event reports received by the US Food and Drug Administration (FDA).MethodsA retrospective disproportionality analysis reporting trends of drug-induced AI was conducted on the FDA Adverse Event Reporting System (FAERS) (> 15 000 000 reports since 2004). AE reports were extracted from FAERS over the past 2 decades. Interventions included cases containing any of the preferred terms in the Medical Dictionary for Regulatory Activities describing AI, and signals of disproportionate reporting for drugs recorded in 10 or more cases as primary suspect.ResultsWe identified 8496 cases of AI: 97.5% serious, 41.1% requiring hospitalization. AI showed an exponential increase throughout the years, with 5282 (62.2%) cases in 2015 to 2020. We identified 56 compounds associated with substantial disproportionality: glucocorticoids (N = 1971), monoclonal antibodies (N = 1644, of which N = 1330 were associated with immune checkpoint inhibitors—ICIs), hormone therapy (N = 291), anti-infectives (N = 252), drugs for hypercortisolism or adrenocortical cancer diagnosis/treatment (N = 169), and protein kinase inhibitors (N = 138). Cases of AI by glucocorticoids were stable in each 5-year period (22%-27%), whereas those by monoclonal antibodies, largely ICIs, peaked from 13% in 2010 to 2015 to 33% in 2015 to 2020.ConclusionWe provide a comprehensive insight into the evolution of drug-induced AI, highlighting the heterogeneous spectrum of culprit drug classes and the emerging increased reporting of ICIs. We claim for the urgent identification of predictive factors for drug-induced AI, and the establishment of screening and educational protocols for patients and caregivers.
The Journal of Clinical Endocrinology & Metabolism – Oxford University Press
Published: Jun 15, 2022
Keywords: adrenal insufficiency; drug-induced; iatrogenic; glucocorticoid; withdrawal; checkpoint; immune checkpoint inhibitors; cancer; FDA; FAERS
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.